Skip to main content
SpringerLink
Log in

Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Positron emission tomography was used to compare the pharmacokinetics of [11C]methylphenidate in the human brain with the temporal course of the subjective and cardiovascular effects observed after intravenous methylphenidate (0.5 mg/kg). Four subjects were tested twice with [11C]methylphenidate, at baseline and after methylphenidate. All subjects showed almost identical uptake of11C labeled drug in brain, as well as a very similar decrease in binding of [11C]methylphenidate in basal ganglia, after pretreatment with methylphenidate. In contrast, the magnitude of the behavioral and cardiovascular changes induced by methylphenidate varied among the subjects. The temporal course for methylphenidate effects paralleled closely the pharmacokinetics of [11C]methylphenidate in brain for the perception of “restlessness” and for changes in systolic blood pressure and heart rate. In contrast, methylphenidate induced “high”, “anxiety” and changes in diastolic blood pressure decreased rapidly despite long lasting binding of the drug in brain. These results indicate that binding of methylphenidate in brain does not appear to predict individual responses to the drug and that more than one neurotransmitter and/or adaptation process are likely to be involved in the behavioral and cardiovascular effects of methylphenidate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Angrist B, Lee HKP, Gershon S (1974) The antagonism of amphetamine-induced symptomatology by a neuroleptic. Am J Psychiatry 131:817–819

    Google Scholar 

  • Angrist B, Rotrosen J, Gershon S (1980) Response to apomorphine, amphetamine and neuroleptics in schizophrenia subjects. Psychopharmacology 67:31–38

    Google Scholar 

  • Aoyama T, Kotaki H, Sawada Y, Iga T (1994) Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites. Pharm Res 11:407–411

    Google Scholar 

  • Blaster RL, Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effects of dose and infusion duration. J Exp Anal Behav 20:119–129

    Google Scholar 

  • Bergman J, Madras B, Johnson SE, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self administration by squirrel monkeys. J Pharmacol Exp Ther 251:150–155

    Google Scholar 

  • Calligaro DO, Eldefrawi ME (1987) Central and peripheral cocaine receptors. J Pharmacol Exp Ther 243:61–68

    Google Scholar 

  • Carroll FI, Lewin AH, Boja JW, Kuhar MJ (1992) Cocaine receptor: biochemical characterization and structure-activity relationship to cocaine analogues at the dopamine transporter. J Med Chem 35:969–981

    Google Scholar 

  • Chait LD (1994) Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol 5:281–288

    Google Scholar 

  • Chait LD, Uhlenhuth EH, Johanson CE (1986) The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol andd-amphetamine in humans. Pharmacol Biochem Behav 24:1665–1672

    Google Scholar 

  • Chait LD, Uhlenhuth EH, Johanson CE (1987) Reinforcing and subjective effects of several anorectics in normal human volunteers. J Pharmacol Exp Ther 242:777–783

    Google Scholar 

  • Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR (1992) Noradrenergic neuronal dysregulation in patients with panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand 86:73–282

    Google Scholar 

  • Cook EC, Jeffcoat RA, Brine DR (1984) Metabolism and pharmacokinetics of drugs. Contract No. 271-80-3705 to NIDA. Research Triangle Institute, North Carolina, pp 141–147

    Google Scholar 

  • Corwin RL, Woolverxton WL, Schuster CR, Johanson CE (1987) Anorectics: effects on food intake and self administration in rhesus monkeys. Alcohol Drug Res 7:351–361

    Google Scholar 

  • de Wit H, Uhlenhuth EH, Johanson CE (1986) Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16:341–360

    Google Scholar 

  • Deminiere IM, Piazza PV, Le Moal M, Simon H (1989) Experimental approach to individual vulnerability to psychostimulant addiction. Neurosci Biobehav Rev 13:141–147

    Google Scholar 

  • Depue RA, Luciana M, Arbisis P, Collins P, Leon A (1994) Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J Person Soc Psychol 67:485–498

    Google Scholar 

  • Deutch AY, Clark WA, Roth RH (1990) Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res 521:311–315

    Google Scholar 

  • Ding Y-S, Fowler JS, Volkow ND, Gatley SJT, Logan J, Dewey S, Alexoff D, Wolf AP (1994) Pharmacokinetics and in vivo specificity of [11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron Synapse 18:152–160

    Google Scholar 

  • Fischman MW, Schuster CR (1981) Cocaine self administration in humans. Fed Proc 41:241–246

    Google Scholar 

  • Foltin RW, Fischman MW (1991) Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257:247–261

    Google Scholar 

  • Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor R, Hitzemann R, Logan J, Bendriem B, Gatley J, Christman D (1989) Mapping cocaine-binding sites in human and baboon brain in vivo. Synapse 4:371–377

    Google Scholar 

  • Fowler JS, Wolf AP, Volkow ND (1990) New directions in positron emission tomography- part II In: Allen RC (ed) Annual reports in medicinal chemistry. Academic Press, New Jersey, pp 261–269

    Google Scholar 

  • Glassman AHS, Stetner F, Walsh T, Raizman PS, Leiss JI, Cooper TB, Covey LS (1988) Heavy smokers, smoking cessation and clonidine. JAMA 2259:2863–2866

    Google Scholar 

  • Grace AA (1995) The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drugs Alcohol Depend 37:115–129

    Google Scholar 

  • Janowsky DS, El-Yousef MK, Davis JM, Sekerke J (1973) Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry 28:185–192

    Google Scholar 

  • Johanson CE, Fischmann MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3–52

    Google Scholar 

  • Joyce PR, Donald RA, Nicholls MG, Lievesey JH, Abbott RM (1986) Endocrine and behavioral responses to methylphenidate in normal subjects. Biol Psychiatry 21:1015–1023

    Google Scholar 

  • Kavoussi RJ, Coccaro E (1993) The amphetamine challenge test correlates with affective liability in healthy volunteers. Psychiatry Res 48:219–228

    Google Scholar 

  • Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715–723

    Google Scholar 

  • Lieberman JA, Alvir J, Geisler S, Ramos-Lorenzi J, Woerner M, Novacenko H, Cooper T, Kane JM (1994) Methylphenidate response, psychopathology and tardive diskinesia as predictors of relapse in schizophrenia. Neuropsychopharmacology 11:107–118

    Google Scholar 

  • Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor RR, Hitzemann R, Bendriem B, Gatley JS, Christman DR (1990) Graphical analyses of reversible radioligand binding from time activity measurements applied toN-11C-methyl-(-) cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740–747

    Google Scholar 

  • Logan J, Volkow ND, Fowler JS, Wang G-J, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P, Hitzemann R, Vitkun S (1994) Effects of blood flow on [11C] raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995–1010

    Google Scholar 

  • Madras BK, Kaufman MJ (1994) Cocaine accumulates in dopamine-rich regions of primate brain after IV administration: comparison with mazindol distribution. Synapse 18:261–275

    Google Scholar 

  • Madras B, Fahey MA, Bergman J, Canfield DR, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. I. [3C] cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131–141

    Google Scholar 

  • Oldendorf WH (1992) Some relationships between addiction and drug delivery to the brain. In Frankenheim J, Brown RM (eds) bioavailability of drugs to the brain and blood brain barrier. Research Monograph 120, National Institue on Drug Abuse. Rockville, pp 13–25

    Google Scholar 

  • Parran TV, Jasinski DR (1991) Intravenous methylphenidate abuse. Prototype for prescription drug abuse. Arch Int Med 151:781–783

    Google Scholar 

  • Patrick KS, Caldwell RW, Ferris RM, Breese GR (1987) Pharmacology of the enantiomers of threo-methylphenidate. J Pharmacol Exp Ther 241:152–158

    Google Scholar 

  • Perez-Reyes M, DiGuiseppi S, Ondrusek G, Jeffcoat A, Cook CE (1982) Free-base cocaine smoking. Clin Pharmacol Ther 32:459–465

    Google Scholar 

  • Redmond DE, Huang YH (1979) New evidence for a locus coeruleus norepinephrine connection with anxiety. Life Sci 25:2149–2162

    Google Scholar 

  • Reith MEA, Sershen H, Allen DL, Lajtha A (1983) A portion of [3H] cocaine binding in brain is associated with serotonergic neurons. Mol Pharmacol 23:600–606

    Google Scholar 

  • Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277–286

    Google Scholar 

  • Ritz MC, Lamb RJ, Goldeberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to the self-administration of cocaine. Science 237:1219–1223

    Google Scholar 

  • Schindler CW, Tella SR, Erzouki HK, Goldberg SR (1995) Pharmacological mechanisms in cocaine's cardiovascular effects. Drug Alcohol Depend 37:183–191

    Google Scholar 

  • Sherer MA, Kumor KM, Jaffe JH (1989) Effects of intravenous cocaine are partially attenutated by haloperidol. Psychiatry Res 27:117–125

    Google Scholar 

  • Schweri MM, Skolnick P, Rafferty MF, Rice KC, Janowsky AJ, Paul SM (1985) [3H]Threo-(±)-methylphenidate uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J Neurochem 45:1062–1070

    Google Scholar 

  • Seeman P (1993) Receptor tables. Vol 2. Drug dissociation for neuroreceptors and transporters. Sz Research, Toronto

    Google Scholar 

  • Srinivas NR, Hubbard JW, Quinn D, Korchinski ED, Midha KK (1991) Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans. Prog Neuro Psychopharmacol Biol-Psychiatry 5:213–220

    Google Scholar 

  • Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll IF, Kuhar MJ (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology (in press)

  • Van Kammen D, Bunney WE, Docherty JP, Marder SR, Ebert MH, Rosenblatt JE, Rayner JN (1982)d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia. Am J Psychiatry 139:991–997

    Google Scholar 

  • Verebey K, Gold MS (1988) From coca leaves to crack: the effects of dose and routes of administration in abuse liability. Psyhiatr Ann 18:513–520

    Google Scholar 

  • Volkow ND, Fowler JS, Wolf AP, Wang G-J, Logan J, MacGregor R, Dewey SL, Schlyer DJ, Hitzemann R (1992) Distribution of11C-cocaine in human heart, lungs, liver and adrenals. A dynamic PET study. J Nucl Med 33:521–525

    Google Scholar 

  • Volkow ND, Wang G-J, Fowler JS, Logan J, Schlyer D, Hitzemann R, Liebermann J, Angrist B, Pappas N, MacGregor R, Burr G, Cooper T, Wolf AP (1994) Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16:255–262

    Google Scholar 

  • Volkow ND, Ding U, Fowler JS, Wang G-J, Logan J, Gatley JS, Dewey SL, Ashby C, Lieberman J, Hitzemann R, Wolf AP (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 52:456–463

    Google Scholar 

  • Von Felsinger JM, Lasagna L, Beecher HK (1995) Drug-induced mood changes in man. 2. Personality and reactions to drugs. JAMA 157:1113–1119

    Google Scholar 

  • Wang G-J, Volkow ND, Hitzemann R, Wong C, Angrist B, Burr G, Pascani K, Pappas N, Lu A, Cooper T, Lieberman J (1995) Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur Addict Res (in press)

  • Wilens TE, Biederman J (1992) The stimulants. Pediatr Psychopharmacol 15:191–222

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department, Building 490, Brookhaven National Laboratory, 11973, Upton, New York, USA

    N. D. Volkow, G. -J. Wang, S. J. Gatley, J. S. Fowler, Y. -S. Ding & J. Logan

  2. Department of Psychiatry, SUNY-Stony Brook, 11794, Stony Brook, New York, USA

    N. D. Volkow & R. Hitzemann

  3. Department of Psychiatry, New York University, New York, NY, USA

    B. Angrist

  4. Hillside Hospital, 11004, Glen Oaks, New York, USA

    J. Lieberman

Authors
  1. N. D. Volkow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. -J. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. J. Gatley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. S. Fowler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. -S. Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Logan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N. D. Volkow
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Hitzemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B. Angrist
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. Lieberman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Volkow, N.D., Wang, G.J., Gatley, S.J. et al. Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects. Psychopharmacology 123, 26–33 (1996). https://doi.org/10.1007/BF02246277

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246277

Key words

Search

Navigation